Amgen Profile

USD 0.05  0.03%

Exercise or conversion by Bonanni Fabrizio of 4000 shares of Amgen subject to Rule 16b-3

Amgen Inc insider trading alert for exercise of common stock by Bonanni Fabrizio, Senior VP Manufacturing, on February 19, 2018. This event was filed by Amgen Inc with SEC on 2005-02-01. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Amgen Summary

Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with current market capitalization of 132.26 B. Amgen Inc conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 720.56 M outstanding shares of which 8.03 M shares are presently shorted by private and institutional investors with about 2.71 trading days to cover. AMGEN currently holds about 41.68 B in cash with 8.55 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 57.84.
Check Amgen Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Amgen Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Amgen Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 39% 
Equity ratings for Amgen Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 20800 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAmgen Inc
ChairmanRobert BradwayAll Leadership
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business AddressOne Amgen Center Drive
Foreign Associates
CIK Number00318154.0
IndustryPharmaceuticals And Biosciences
Contact Number805 447 1000
CurrencyUSD - US Dollar


Amgen Analyst Recommendations
Target PriceAdvice# of Analysts
Amgen Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Amgen Analyst Advice  

Amgen Dividends

Upcoming distributions to stockholders


Amgen Earnings Estimates
EPSEstimate Date
Quarterly Estimate2.99April 27, 2017
Amgen Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


Amgen Corporate Directors
Frank Herringer Independent Director
Francois Carbonnel Independent Director
Rebecca Henderson Independent Director, Ph.D